NIH Schedules Closed Virtual Grant Review Meetings
Published Date: 6/2/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
NIH closed virtual grant review meetings
The NIH Center for Scientific Review will hold closed virtual meetings on June 30, 2026 and July 1, 2026 to review and evaluate grant applications. The meetings are closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) and may discuss confidential trade secrets, patentable material, and personal information related to applicants.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14980, Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration
The National Eye Institute has a cool new invention using special peptides to help protect eyes from inherited diseases like retinitis pigmentosa, which causes vision loss for over 100,000 Americans. They’re looking for partners to help develop easy-to-use eyedrops or gene therapy to slow down or stop this eye damage. This could bring hope and new treatments to many people with few options, and interested parties can start talking to the NIH now!
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
2026-14981, Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia (AML)
The government has developed special T cell receptors that can target a tough type of blood cancer called acute myeloid leukemia (AML), especially in patients with a specific genetic marker. These new receptors promise safer, more precise treatment with fewer side effects than current options. Researchers and companies can now license this invention to help bring this exciting therapy to patients faster.
2026-14848, Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS
The National Institutes of Health plans to give Modala Bio an exclusive license to use new RXFP1 agonist inventions that could help treat diseases like cancer, heart failure, and fibrosis. This means Modala Bio gets special rights to develop and sell these promising medicines worldwide. If you want to comment or apply for a license, you have until August 24, 2026, so don’t miss out!
2026-14752, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in August 2026 to review and evaluate important grant and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding to fight antibiotic resistance, support schizophrenia research, and boost medical tech. If you’re involved in these fields, keep an eye on these dates—they could impact future research dollars and projects.
Previous / Next Documents
Previous: 2026-11016, Commercial Driver's License: Jenifer Sanchez Vilchis; Application for Exemption
Jenifer Sanchez Vilchis wants DACA recipients with work permits to get Class B passenger Commercial Driver's Licenses just like other workers. The government is asking the public to share their thoughts by July 2, 2026, before deciding. If approved, this could open new job opportunities for many without extra costs or delays.
Next: 2026-11019, Agency Information Collection Activities; Extension; Cargo Manifest/Declaration, Stow Plan, Container Status Messages and Importer Security Filing
U.S. Customs and Border Protection is asking to keep collecting important shipping info like cargo manifests, stow plans, and container updates. This affects importers and shipping companies who must keep sharing these details to help keep trade safe and smooth. They want your feedback by August 3, 2026, but no new fees or big changes are coming—just an extension to keep things running.